CoChat

Early complement genes are associated with visual system degeneration in multiple sclerosis

Fitzgerald, Kathryn C, Kim, Kicheol, Smith, Matthew D, Aston, Sean A, Fioravante, Nicholas, Rothman, Alissa M, Krieger, Stephen, Cofield, Stacey S, Kimbrough, Dorlan J, Bhargava, Pavan, Saidha, Shiv, Whartenby, Katharine A, Green, Ari J, Mowry, Ellen M, Cutter, Gary R, Lublin, Fred D, Baranzini, Sergio E, De Jager, Philip L, Calabresi, Peter A · 2019 · Brain
Cited by 49

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Multiple sclerosis is a heterogeneous disease with an unpredictable course and a wide range of severity; some individuals rapidly progress to a disabled state whereas others experience only mild symptoms. Though genetic studies have identified variants that are associated with an increased risk of developing multiple sclerosis, no variants have been consistently associated with multiple sclerosis severity. In part, the lack of findings is related to inherent limitations of clinical rating scales; these scales are insensitive to early degenerative changes that underlie disease progression. Optical coherence tomography imaging of the retina and low-contrast letter acuity correlate with and predict clinical and imaging-based outcomes in multiple sclerosis. Therefore, they may serve as sensitive phenotypes to discover genetic predictors of disease course. We conducted a set of genome-wide association studies of longitudinal structural and functional visual pathway phenotypes in multiple sclerosis. First, we assessed genetic predictors of ganglion cell/inner plexiform layer atrophy in a discovery cohort of 374 patients with multiple sclerosis using mixed-effects models adjusting for age, sex, disease duration, optic neuritis and genetic ancestry and using a combination of single-variant and network-based analyses. For candidate variants identified in discovery, we conducted a similar set of analyses of ganglion cell/inner plexiform layer thinning in a replication cohort (n = 376). Second, we assessed genetic predictors of sustained loss of 5-letters in low-contrast letter acuity in discovery (n = 582) using multivariable-adjusted Cox proportional hazards models. We then evaluated candidate variants/pathways in a replication cohort. (n = 253). Results of both studies revealed novel subnetworks highly enriched for connected genes in early complement activation linked to measures of disease severity. Within these networks, C3 was the gene most strongly associated with ganglion cell/inner plexiform layer atrophy (P = 0.004) and C1QA and CR1 were top results in analysis of sustained low-contrast letter acuity loss. Namely, variant rs158772, linked to C1QA, and rs61822967, linked to CR1, were associated with 71% and 40% increases in risk of sustained LCLA loss, respectively, in meta-analysis pooling discovery and replication cohorts (rs158772: hazard ratio: 1.71; 95% confidence interval 1.30–2.25; P = 1.3 × 10−4; rs61822967: hazard ratio: 1.40; 95% confidence interval: 1.16–1.68; P = 4.1 × 10−4). In conclusion, early complement pathway gene variants were consistently associated with structural and functional measures of multiple sclerosis severity. These results from unbiased analyses are strongly supported by several prior reports that mechanistically implicated early complement factors in neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awz188

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 44

  1. Balcer, 2012, Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing multiple sclerosis, J Neurol Sci, 318, 119, 10.1016/j.jns.2012.03.009 · DOI
  2. Balcer, 2017, Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis, Mult Scler, 23, 734, 10.1177/1352458517690822 · DOI · Paper page
  3. Balk, 2016, Timing of retinal neuronal and axonal loss in multiple sclerosis: a longitudinal OCT study, J Neurol, 263, 1323, 10.1007/s00415-016-8127-y · DOI · Paper page
  4. Baranzini, 2009, Pathway and network-based analysis of genome-wide association studies in multiple sclerosis, Hum Mol Genet, 18, 2078, 10.1093/hmg/ddp120 · DOI · Paper page
  5. Baranzini, 2010, Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis, Brain, 133, 2603, 10.1093/brain/awq192 · DOI · Paper page
  6. Beck, 2007, Visual acuity as an outcome measure in clinical trials of retinal diseases, Ophthalmology, 114, 1804, 10.1016/j.ophtha.2007.06.047 · DOI · Paper page
  7. De Jager, 2012, A genome-wide scan for common variants affecting the rate of age-related cognitive decline, Neurobiol Aging, 33, 1017.e1, 10.1016/j.neurobiolaging.2011.09.033 · DOI · Paper page
  8. Estrada, 2018, A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica, Nat Commun, 9, 1929, 10.1038/s41467-018-04332-3 · DOI
  9. Gourraud, 2013, A genome-wide association study of brain lesion distribution in multiple sclerosis, Brain, 136, 1012, 10.1093/brain/aws363 · DOI
  10. Housley, 2015, Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli, Sci Transl Med, 7, 291ra93, 10.1126/scitranslmed.aaa9223 · DOI
  11. Isobe, 2016, Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis, JAMA Neurol, 73, 795, 10.1001/jamaneurol.2016.0980 · DOI
  12. Jager, 2009, Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score, Lancet Neurol, 8, 1111, 10.1016/S1474-4422(09)70275-3 · DOI · Paper page
  13. Jia, 2013, Imputing amino acid polymorphisms in human leukocyte antigens, PLoS One, 8, e64683, 10.1371/journal.pone.0064683 · DOI · Paper page
  14. Kamburov, 2013, The ConsensusPathDB interaction database: 2013 update, Nucleic Acids Res, 41, D793, 10.1093/nar/gks1055 · DOI · Paper page
  15. Katz, 2014, Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state, Elife, 3, e03915, 10.7554/eLife.03915 · DOI · Paper page
  16. Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease, Nat Genet, 45, 1452, 10.1038/ng.2802 · DOI · Paper page
  17. Leiserson, 2015, Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes, Nat. Genet, 47, 106, 10.1038/ng.3168 · DOI · Paper page
  18. Lindsey, 2012, The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting multiple sclerosis: design and baseline characteristics, Mult Scler Relat Disord, 1, 81, 10.1016/j.msard.2012.01.006 · DOI
  19. Lublin, 2013, Randomized study combining interferon & glatiramer acetate in multiple sclerosis, Ann Neurol, 73, 327, 10.1002/ana.23863 · DOI · Paper page
  20. Maghzi, 2014, Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis, Mult Scler Relat Disord, 3, 720, 10.1016/j.msard.2014.07.003 · DOI
  21. Martinez-Lapiscina, 2016, Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study, Lancet Neurol, 15, 574, 10.1016/S1474-4422(16)00068-5 · DOI · Paper page
  22. Matsushita, 2015, Genetic associations with brain cortical thickness in multiple sclerosis, Genes Brain Behav, 14, 217, 10.1111/gbb.12190 · DOI
  23. Michailidou, 2017, Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: implication for disease pathogenesis, Glia, 65, 264, 10.1002/glia.23090 · DOI · Paper page
  24. Michailidou, 2015, Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus, Ann Neurol, 77, 1007, 10.1002/ana.24398 · DOI · Paper page
  25. Morgan, 2017, Molecular cell biology of complement membrane attack, Semin Cell Dev Biol, 72, 124, 10.1016/j.semcdb.2017.06.009 · doi:10.1016/j.semcdb.2017.06.009
  26. Murphy, 2016, The Musashi 1 controls the splicing of photoreceptor-specific exons in the vertebrate retina, PLoS Genet, 12, e1006256, 10.1371/journal.pgen.1006256 · DOI · Paper page
  27. Nakka, 2016, Gene and network analysis of common variants reveals novel associations in multiple complex diseases, Genetics, 204, 783, 10.1534/genetics.116.188391 · DOI
  28. Orsini, 2014, Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis, Front Cell Neurosci, 8, 380, 10.3389/fncel.2014.00380 · DOI · Paper page
  29. Reed, 2015, A guide to genome-wide association analysis and post-analytic interrogation, Stat Med, 34, 3769, 10.1002/sim.6605 · DOI
  30. Razick, 2008, iRefIndex: A consolidated protein interaction database with provenance, BMC Bioinform, 9, 405, 10.1186/1471-2105-9-405 · DOI · Paper page
  31. Roostaei, 2019, Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis, Mult Scler, 25, 532, 10.1177/1352458518760715 · DOI
  32. Saidha, 2015, Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study, Ann Neurol, 78, 801, 10.1002/ana.24487 · DOI · Paper page
  33. Scarr, 2016, Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia, npj Schizophrenia, 2, 16002, 10.1038/npjschz.2016.2 · DOI · Paper page
  34. Scolding, 1998, The expression of complement regulatory proteins by adult human oligodendrocytes, J Neuroimmunol, 84, 69, 10.1016/S0165-5728(97)00241-5 · DOI
  35. Stevens, 2007, The classical complement cascade mediates CNS synapse elimination, Cell, 131, 1164, 10.1016/j.cell.2007.10.036 · DOI · Paper page
  36. Syc, 2012, Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis, Brain, 135, 521, 10.1093/brain/awr264 · DOI · Paper page
  37. Talman, 2010, Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis, Ann Neurol, 67, 749, 10.1002/ana.22005 · DOI · Paper page
  38. Trip, 2005, Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis, Ann Neurol, 58, 383, 10.1002/ana.20575 · DOI · Paper page
  39. Vanderweele, 2014, Effect decomposition in the presence of an exposure-induced mediator-outcome confounder, Epidemiology, 25, 300, 10.1097/EDE.0000000000000034 · DOI · Paper page
  40. Verma, 2014, Imputation and quality control steps for combining multiple genome-wide datasets, Front Genet, 5, 370, 10.3389/fgene.2014.00370 · DOI · Paper page
  41. Watkins, 2016, Complement is activated in progressive multiple sclerosis cortical grey matter lesions, J Neuroinflamm, 13, 161, 10.1186/s12974-016-0611-x · DOI · Paper page
  42. Willer, 2010, METAL: fast and efficient meta-analysis of genomewide association scans, Bioinformatics, 26, 2190, 10.1093/bioinformatics/btq340 · DOI · Paper page
  43. Wing, 1999, Comparison of C1q-receptors on rat microglia and peritoneal macrophages, J Neuroimmunol, 94, 74, 10.1016/S0165-5728(98)00227-6 · DOI
  44. Wu, 2007, Relation of vision to global and regional brain MRI in multiple sclerosis, Neurology, 69, 2128, 10.1212/01.wnl.0000278387.15090.5a · DOI

Cited by

See all 49

Metadata

Authors
Fitzgerald, K. C., Kim, K., Smith, M. D., Aston, S. A., Fioravante, N., Rothman, A. M., Krieger, S., Cofield, S. S., Kimbrough, D. J., Bhargava, P., Saidha, S., Whartenby, K. A., Green, A. J., Mowry, E. M., Cutter, G. R., Lublin, F. D., Baranzini, S. E., De Jager, P. L., & Calabresi, P. A.
Affiliations
  • Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA
  • Department of Neurology, University of California San Francisco, San Francisco, CA, USA
  • Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
  • Department of Neurology, Harvard Medical School, Boston, MA, USA
  • Center for Translational and Computational Neuroimmunology, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Venue
Brain
Published
2019-07-09
Volume
142
Issue
9
Pages
2722-2736
ISSN
  • 0006-8950
  • 1460-2156
Cited by
49
References
12
Language
en
Funders
  • National Institutes of Health
  • NIH (R01NS082347, R01NS088155)
  • National Multiple Sclerosis Society
  • National Institute of Neurological Disorders and Stroke (UO1NS045719, R21NS41986, NCT00211887)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early complement genes are associated with visual system degeneration in multiple sclerosis. https://app.cochat.ai/papers/10.1093/brain/awz188
The paper
Fitzgerald, K. C., Kim, K., Smith, M. D., Aston, S. A., Fioravante, N., Rothman, A. M., Krieger, S., Cofield, S. S., Kimbrough, D. J., Bhargava, P., Saidha, S., Whartenby, K. A., Green, A. J., Mowry, E. M., Cutter, G. R., Lublin, F. D., Baranzini, S. E., De Jager, P. L., & Calabresi, P. A. (2019). Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain. https://doi.org/10.1093/brain/awz188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.